Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 10 studies | 49% ± 16% | |
epithelial cell | 9 studies | 33% ± 13% | |
club cell | 5 studies | 21% ± 3% | |
epithelial cell of proximal tubule | 5 studies | 26% ± 12% | |
basal cell | 4 studies | 29% ± 18% | |
duct epithelial cell | 4 studies | 31% ± 13% | |
secretory cell | 4 studies | 21% ± 3% | |
kidney loop of Henle epithelial cell | 4 studies | 23% ± 4% | |
abnormal cell | 4 studies | 32% ± 10% | |
respiratory goblet cell | 3 studies | 24% ± 2% | |
transit amplifying cell | 3 studies | 29% ± 9% | |
retina horizontal cell | 3 studies | 17% ± 1% | |
fibroblast | 3 studies | 21% ± 3% | |
hepatocyte | 3 studies | 44% ± 25% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 25% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 4021.67 | 243 / 245 | 100% | 143.82 | 500 / 502 |
liver | 99% | 5421.70 | 223 / 226 | 98% | 97.32 | 396 / 406 |
kidney | 100% | 3224.64 | 89 / 89 | 95% | 95.27 | 855 / 901 |
thymus | 100% | 2865.90 | 650 / 653 | 93% | 65.80 | 563 / 605 |
ovary | 100% | 4858.18 | 180 / 180 | 91% | 44.52 | 393 / 430 |
pancreas | 100% | 7990.48 | 328 / 328 | 89% | 42.27 | 158 / 178 |
uterus | 96% | 1660.05 | 163 / 170 | 89% | 57.03 | 407 / 459 |
intestine | 99% | 3973.04 | 956 / 966 | 85% | 45.78 | 449 / 527 |
stomach | 98% | 3619.83 | 353 / 359 | 78% | 35.28 | 222 / 286 |
lung | 91% | 1392.86 | 525 / 578 | 82% | 40.24 | 947 / 1155 |
breast | 75% | 1304.44 | 346 / 459 | 96% | 73.20 | 1071 / 1118 |
bladder | 95% | 2290.48 | 20 / 21 | 72% | 31.95 | 362 / 504 |
esophagus | 93% | 1936.03 | 1347 / 1445 | 72% | 22.04 | 131 / 183 |
adrenal gland | 100% | 6166.53 | 257 / 258 | 45% | 25.83 | 103 / 230 |
skin | 92% | 2520.47 | 1663 / 1809 | 33% | 9.53 | 156 / 472 |
muscle | 100% | 19525.69 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 48.83 | 1 / 1 |
blood vessel | 97% | 2205.13 | 1291 / 1335 | 0% | 0 | 0 / 0 |
heart | 94% | 2662.48 | 813 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 51.03 | 40 / 45 |
eye | 0% | 0 | 0 / 0 | 86% | 36.01 | 69 / 80 |
adipose | 68% | 952.54 | 817 / 1204 | 0% | 0 | 0 / 0 |
spleen | 49% | 464.05 | 118 / 241 | 0% | 0 | 0 / 0 |
brain | 8% | 68.27 | 223 / 2642 | 17% | 4.59 | 122 / 705 |
peripheral blood | 3% | 37.58 | 25 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0006368 | Biological process | transcription elongation by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | TCEA3 |
Protein name | Transcription elongation factor A protein 3 (Transcription elongation factor S-II protein 3) (Transcription elongation factor TFIIS.h) Transcription elongation factor A protein 3 (Transcription elongation factor A3) Transcription elongation factor |
Synonyms | TFIISH |
Description | FUNCTION: Necessary for efficient RNA polymerase II transcription elongation past template-encoded arresting sites. The arresting sites in DNA have the property of trapping a certain fraction of elongating RNA polymerases that pass through, resulting in locked ternary complexes. Cleavage of the nascent transcript by S-II allows the resumption of elongation from the new 3'-terminus. FUNCTION: Necessary for efficient RNA polymerase II transcription elongation past template-encoded arresting sites. The arresting sites in DNA have the property of trapping a certain fraction of elongating RNA polymerases that pass through, resulting in locked ternary complexes. Cleavage of the nascent transcript by S-II allows the resumption of elongation from the new 3'-terminus. . |
Accessions | ENST00000635356.1 ENST00000635497.2 ENST00000374601.7 [O75764-2] ENST00000476978.2 ENST00000461794.1 S4R419 S4R3M9 ENST00000450454.7 [O75764-1] ENST00000634832.1 [O75764-2] O75764 ENST00000635035.2 [O75764-1] |